Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

P. Musto; L. Maurillo; V. Simeon; A. Poloni; C. Finelli; E. Balleari; A. Ricco; F. Rivellini; A. Cortelezzi; G. Tarantini; O. Villani; G. Mansueto; M.R. Milella; D. Scapicchio; G. Marziano; M. Breccia; P. Niscola; A. Sanna; C. Clissa; M.T. Voso; S. Fenu; A. Venditti; V. Santini; E. Angelucci; A. Levis

doi:10.1111/bjh.14621

Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

P. Musto, L. Maurillo, V. Simeon, A. Poloni, C. Finelli, E. Balleari, A. Ricco, F. Rivellini, A. Cortelezzi, G. Tarantini, O. Villani, G. Mansueto, M.R. Milella, D. Scapicchio, G. Marziano, M. Breccia, P. Niscola, A. Sanna, C. Clissa, M.T. VosoS. Fenu, A. Venditti, V. Santini, E. Angelucci, A. Levis

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	741-750
Number of pages	10
Journal	British Journal of Haematology
Volume	177
Issue number	5
DOIs	https://doi.org/10.1111/bjh.14621
Publication status	Published - 2017

Access to Document

10.1111/bjh.14621

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017559356&doi=10.1111%2fbjh.14621&partnerID=40&md5=fdfdc7ce0ed1b1041d90b101a69389c0

Cite this

Musto, P., Maurillo, L., Simeon, V., Poloni, A., Finelli, C., Balleari, E., Ricco, A., Rivellini, F., Cortelezzi, A., Tarantini, G., Villani, O., Mansueto, G., Milella, M. R., Scapicchio, D., Marziano, G., Breccia, M., Niscola, P., Sanna, A., Clissa, C., ... Levis, A. (2017). Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study. British Journal of Haematology, 177(5), 741-750. https://doi.org/10.1111/bjh.14621

Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study. / Musto, P.; Maurillo, L.; Simeon, V.; Poloni, A.; Finelli, C.; Balleari, E.; Ricco, A.; Rivellini, F.; Cortelezzi, A.; Tarantini, G.; Villani, O.; Mansueto, G.; Milella, M.R.; Scapicchio, D.; Marziano, G.; Breccia, M.; Niscola, P.; Sanna, A.; Clissa, C.; Voso, M.T.; Fenu, S.; Venditti, A.; Santini, V.; Angelucci, E.; Levis, A.

In: British Journal of Haematology, Vol. 177, No. 5, 2017, p. 741-750.

Research output: Contribution to journal › Article

Musto, P, Maurillo, L, Simeon, V, Poloni, A, Finelli, C, Balleari, E, Ricco, A, Rivellini, F, Cortelezzi, A, Tarantini, G, Villani, O , Mansueto, G , Milella, MR, Scapicchio, D, Marziano, G, Breccia, M, Niscola, P, Sanna, A, Clissa, C, Voso, MT, Fenu, S, Venditti, A, Santini, V, Angelucci, E & Levis, A 2017, 'Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study', British Journal of Haematology, vol. 177, no. 5, pp. 741-750. https://doi.org/10.1111/bjh.14621

Musto, P. ; Maurillo, L. ; Simeon, V. ; Poloni, A. ; Finelli, C. ; Balleari, E. ; Ricco, A. ; Rivellini, F. ; Cortelezzi, A. ; Tarantini, G. ; Villani, O. ; Mansueto, G. ; Milella, M.R. ; Scapicchio, D. ; Marziano, G. ; Breccia, M. ; Niscola, P. ; Sanna, A. ; Clissa, C. ; Voso, M.T. ; Fenu, S. ; Venditti, A. ; Santini, V. ; Angelucci, E. ; Levis, A. / Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study. In: British Journal of Haematology. 2017 ; Vol. 177, No. 5. pp. 741-750.

@article{18c8d07561484d7782150ff487643d7b,

title = "Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study",

author = "P. Musto and L. Maurillo and V. Simeon and A. Poloni and C. Finelli and E. Balleari and A. Ricco and F. Rivellini and A. Cortelezzi and G. Tarantini and O. Villani and G. Mansueto and M.R. Milella and D. Scapicchio and G. Marziano and M. Breccia and P. Niscola and A. Sanna and C. Clissa and M.T. Voso and S. Fenu and A. Venditti and V. Santini and E. Angelucci and A. Levis",

note = "Cited By :1 Export Date: 30 October 2017 CODEN: BJHEA Correspondence Address: Musto, P.; Scientific Direction, IRCCS-CROB, Referral Cancer Centre of BasilicataItaly; email: p.musto@crob.it",

year = "2017",

doi = "10.1111/bjh.14621",

language = "English",

volume = "177",

pages = "741--750",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley & Sons, Ltd (10.1111)",

number = "5",

}

TY - JOUR

T1 - Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

AU - Musto, P.

AU - Maurillo, L.

AU - Simeon, V.

AU - Poloni, A.

AU - Finelli, C.

AU - Balleari, E.

AU - Ricco, A.

AU - Rivellini, F.

AU - Cortelezzi, A.

AU - Tarantini, G.

AU - Villani, O.

AU - Mansueto, G.

AU - Milella, M.R.

AU - Scapicchio, D.

AU - Marziano, G.

AU - Breccia, M.

AU - Niscola, P.

AU - Sanna, A.

AU - Clissa, C.

AU - Voso, M.T.

AU - Fenu, S.

AU - Venditti, A.

AU - Santini, V.

AU - Angelucci, E.

AU - Levis, A.

N1 - Cited By :1 Export Date: 30 October 2017 CODEN: BJHEA Correspondence Address: Musto, P.; Scientific Direction, IRCCS-CROB, Referral Cancer Centre of BasilicataItaly; email: p.musto@crob.it

PY - 2017

Y1 - 2017

U2 - 10.1111/bjh.14621

DO - 10.1111/bjh.14621

M3 - Article

VL - 177

SP - 741

EP - 750

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 5

ER -